Antibiotic combinations with redundant antimicrobial spectra: Clinical epidemiology and pilot intervention of computer-assisted surveillance

被引:61
作者
Glowacki, RC
Schwartz, DN
Itokazu, GS
Wisniewski, MF
Kieszkowski, P
Weinstein, RA
机构
[1] John H Stroger Jr Hosp Cook Cty, Div Infect Dis, Chicago, IL 60612 USA
[2] Univ Illinois, Coll Pharm, Chicago, IL USA
[3] Rush Med Coll, Chicago, IL 60612 USA
关键词
D O I
10.1086/376623
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Redundant antibiotic combinations are a potentially remediable source of antibiotic overuse. At a public teaching hospital, we determined the incidence, cost, and indications for such combinations and measured the effects of a pharmacist-based intervention. Of 1189 inpatients receiving greater than or equal to2 antibiotics, computer-assisted screening identified 192 patients (16.1%) receiving potentially redundant combinations. Chart reviews showed that 137 episodes (71%) were inappropriate. Physician overprescribing errors were found in 77 episodes (56%); most involved redundant coverage for gram-positive or anaerobic organisms. In 76 episodes (55%), lapses in the medication ordering and distribution system led to the persistence in the pharmacy records of regimens no longer active according to the patient charts. The incidence of redundant antibiotic combinations was significantly higher in the intensive care unit and surgery services, compared with medical services. Interventions to discontinue redundant agents were successful in 134 (98%) of the 137 episodes. Potential drug cost savings and reduction in redundant antibiotic combination days were $10,800 and 584 days, respectively; pharmacist time for patient review and intervention cost $2880. Use of redundant antibiotic combinations was common, and a pharmacist-based intervention was feasible, with a potential annualized cost savings of $48,000.
引用
收藏
页码:59 / 64
页数:6
相关论文
共 21 条
  • [1] The pandemic of antibiotic resistance
    Anderson, RM
    [J]. NATURE MEDICINE, 1999, 5 (02) : 147 - 149
  • [2] [Anonymous], [No title captured]
  • [3] Bailey TC, 1997, PHARMACOTHERAPY, V17, P277
  • [4] ANTIBIOTIC-ASSOCIATED DIARRHEA
    BARTLETT, JG
    [J]. CLINICAL INFECTIOUS DISEASES, 1992, 15 (04) : 573 - 581
  • [5] Evaluating treatment protocols to prevent antibiotic resistance
    Bonhoeffer, S
    Lipsitch, M
    Levin, BR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (22) : 12106 - 12111
  • [6] Monotherapy versus combination therapy for bacterial infections
    Bouza, E
    Muñoz, P
    [J]. MEDICAL CLINICS OF NORTH AMERICA, 2000, 84 (06) : 1357 - +
  • [7] PHARMACISTS IMPACT ON ANTIMICROBIAL DRUG-THERAPY
    CADLE, RM
    DAROUICHE, RO
    TIBBETTS, CS
    GRAVISS, E
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1995, 52 (14) : 1544 - 1546
  • [8] Antimicrobial resistance in intensive care units
    Fridkin, SK
    Gaynes, RP
    [J]. CLINICS IN CHEST MEDICINE, 1999, 20 (02) : 303 - +
  • [9] GLOWACKI R, 2001, 11 ANN SCI M SOC HEA, P91
  • [10] Hoolihan R J, 1987, Hosp Pharm, V22, P871